Cargando…
MAP4K3/GLK in autoimmune disease, cancer and aging
MAP4K3 (also named GLK) is a serine/threonine kinase, which belongs to the mammalian Ste20-like kinase family. At 22 years of age, GLK was initially cloned and identified as an upstream activator of the MAPK JNK under an environmental stress and proinflammatory cytokines. The data derived from GLK-o...
Autores principales: | Chuang, Huai-Chia, Tan, Tse-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806545/ https://www.ncbi.nlm.nih.gov/pubmed/31640697 http://dx.doi.org/10.1186/s12929-019-0570-5 |
Ejemplares similares
-
GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer
por: Hsu, Chung-Ping, et al.
Publicado: (2016) -
Genomic sequencing and functional analyses identify MAP4K3/GLK germline and somatic variants associated with systemic lupus erythematosus
por: Chuang, Huai-Chia, et al.
Publicado: (2022) -
SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
por: Chuang, Huai‐Chia, et al.
Publicado: (2022) -
Germinal center kinase-like kinase (GLK/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker
por: Chen, Der-Yuan, et al.
Publicado: (2012) -
GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease
por: Chuang, Huai-Chia, et al.
Publicado: (2018)